Рецепт. 2020; : 377-384
Заболевания щитовидной и паращитовидной желез в условиях пандемии COVID-19
https://doi.org/10.34883/PI.2020.2.2.044Аннотация
Рационализация диагностических протоколов при заболеваниях щитовидной и паращитовидной желез в условиях COVID-19 оговорена международными рекомендациями 2020 г. Ведение пациентов с иммунным и неиммунным тиреотоксикозом и COVID-19 имеет ряд особенностей. На фоне высокой заболеваемости COVID-19 основным источником выявления новых случаев узловых образований щитовидной железы будут результаты КТ у пациентов с нарушениями дыхания или пневмонией. Большинство объемных новообразований являются доброкачественными, и даже при обнаружении злокачественного новообразования щитовидной железы проблема проведения отсроченного хирургического лечения через несколько месяцев не представляет особого риска для жизни. Тонкоигольные аспирационные биопсии (TAБ) щитовидной железы и операции у пациентов с подозрением на COVID-19 могут быть безопасно отложены до клинического выздоровления.
Список литературы
1. AACE Position Statement: Coronavirus (COVID-19) and People with Thyroid Disease. https://www.aace.com/recent-news-and-updates/aace-position-statement-coronavirus-covid-19-and-people-thyroid-disease
2. Centers for Disease Control (CDC) website: https://www.cdc.gov/coronavirus/2019-ncov/index.html
3. Center for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). (2020). https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/clinical-guidance-management-patients.html#
4. Li M. (2020) Considerations for Thyroid Fine Needle Aspiration (FNA) Biopsies During the COVID-19 Pandemic. Clinical Thyroidology, vol. 32, no 4, pp. 157–159.
5. Durante C. (2018) The diagnosis and management of thyroid nodules: a review. JAMA, vol. 319, pp. 914–24.
6. Lushchyk M.L. (2019) Trends in thyroid cancer incidence in young population of Brest region of Belarus. 89th Annual Meeting of the American Thyroid Association (Chicago, Illinois, USA, October 31 – November 3, 2019). Thyroid, vol. 29, supplement 1, 2019. doi: 10.1089/thy.2019.29085. abstracts
7. U.S. Preven ve Services Task Force, Bibbins-Domingo K., Grossman D.C., Curry S.J., Barry M.J., Davidson K.W., Doubeni C.A., Epling J.W. Jr, Kemper A.R., Krist A.H. (2017) Screening for thyroid cancer: U.S. preventive services task force recommendation statement. JAMA, vol. 317, pp. 1882–1887.
8. Ross D.S. (2016) American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid, pp. 1–272.
9. Danillova L.I. (2008) Shchitovidnaya zheleza i lekarstvennyye preparaty [Thyroid and medications]. ARS medica. Iskusstvo meditsiny, no 2–3, pp. 11–14.
10. Joshi S.R. (2020) Effect of levothyroxine dosing before breakfast versus at bedtime. Hyperthyroidism, pp. 159–161. doi.org/10.1089/ ct.2020;32.159-161.
11. Hurtado C., Yeh M.W., Livhits M.J. (2020) Antithyroid medications are the most common treatment for graves’ disease in the united states despite high rates of treatment failure, Hyperthyroidism, pp. 162–165. doi.org/10.1089/ct.2020;32.162-165.
12. Angell T.E. (2020) New recommendations for the management of thyroid dysfunction and thyroid enlargement in the United Kingdom. Thyroid, vol. 32, no 3, pp. 102–105.
13. Lee S.Y. (2020) Thyroidectomy may improve survival in patients with moderate to severe cardiac dysfunction and amiodarone-induced thyrotoxicosis compared to medical treatment. Hyperthyroidism, pp. 174177.
14. Danilova L.I. (2004) Bolezni shchitovidnoy zhelezy i assotsiirovannyye zabolevaniya [Thyroid Diseases and Associated Diseases]. Minsk-Nagasaki, pp. 472.
15. Lushchyk M. (2018) Vitamin D receptor (VDR) polymorphisms variations in patients with differentiated thyroid cancer. 88th Annual Meeting of the American Thyroid Association (Washington, DC, USA October 1–5 2018).
16. Bouillon R. (2019) Skeletal and extra-skeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev., vol. 40, no 4, pp. 1109–1151.
17. Schini M. (2020) Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History. J Clin Endocrinol Metab, vol. 105, pp. 1–13.
18. Eastell R. (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab, vol. 99, no 10, pp. 3570–3579.
19. Grant W.B. (2020) Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients,
20. vol. 12. pp. 988–996. doi:10.3390/nu12040988 www.mdpi.com/journal/nutr
21. Khan A.A. (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. European Journal of Endocrinology, no 180, pp. 1–23.
Recipe. 2020; : 377-384
Thyroid and Parathyroid Diseases in the Context of the COVID-19 Pandemic
https://doi.org/10.34883/PI.2020.2.2.044Abstract
References
1. AACE Position Statement: Coronavirus (COVID-19) and People with Thyroid Disease. https://www.aace.com/recent-news-and-updates/aace-position-statement-coronavirus-covid-19-and-people-thyroid-disease
2. Centers for Disease Control (CDC) website: https://www.cdc.gov/coronavirus/2019-ncov/index.html
3. Center for Disease Control and Prevention. Interim clinical guidance for management of patients with confirmed coronavirus disease (COVID-19). (2020). https://www.cdc.gov/coronavirus/ 2019-ncov/hcp/clinical-guidance-management-patients.html#
4. Li M. (2020) Considerations for Thyroid Fine Needle Aspiration (FNA) Biopsies During the COVID-19 Pandemic. Clinical Thyroidology, vol. 32, no 4, pp. 157–159.
5. Durante C. (2018) The diagnosis and management of thyroid nodules: a review. JAMA, vol. 319, pp. 914–24.
6. Lushchyk M.L. (2019) Trends in thyroid cancer incidence in young population of Brest region of Belarus. 89th Annual Meeting of the American Thyroid Association (Chicago, Illinois, USA, October 31 – November 3, 2019). Thyroid, vol. 29, supplement 1, 2019. doi: 10.1089/thy.2019.29085. abstracts
7. U.S. Preven ve Services Task Force, Bibbins-Domingo K., Grossman D.C., Curry S.J., Barry M.J., Davidson K.W., Doubeni C.A., Epling J.W. Jr, Kemper A.R., Krist A.H. (2017) Screening for thyroid cancer: U.S. preventive services task force recommendation statement. JAMA, vol. 317, pp. 1882–1887.
8. Ross D.S. (2016) American Thyroid Association Guidelines for Diagnosis and Management of Hyperthyroidism and other causes of Thyrotoxicosis. Thyroid, pp. 1–272.
9. Danillova L.I. (2008) Shchitovidnaya zheleza i lekarstvennyye preparaty [Thyroid and medications]. ARS medica. Iskusstvo meditsiny, no 2–3, pp. 11–14.
10. Joshi S.R. (2020) Effect of levothyroxine dosing before breakfast versus at bedtime. Hyperthyroidism, pp. 159–161. doi.org/10.1089/ ct.2020;32.159-161.
11. Hurtado C., Yeh M.W., Livhits M.J. (2020) Antithyroid medications are the most common treatment for graves’ disease in the united states despite high rates of treatment failure, Hyperthyroidism, pp. 162–165. doi.org/10.1089/ct.2020;32.162-165.
12. Angell T.E. (2020) New recommendations for the management of thyroid dysfunction and thyroid enlargement in the United Kingdom. Thyroid, vol. 32, no 3, pp. 102–105.
13. Lee S.Y. (2020) Thyroidectomy may improve survival in patients with moderate to severe cardiac dysfunction and amiodarone-induced thyrotoxicosis compared to medical treatment. Hyperthyroidism, pp. 174177.
14. Danilova L.I. (2004) Bolezni shchitovidnoy zhelezy i assotsiirovannyye zabolevaniya [Thyroid Diseases and Associated Diseases]. Minsk-Nagasaki, pp. 472.
15. Lushchyk M. (2018) Vitamin D receptor (VDR) polymorphisms variations in patients with differentiated thyroid cancer. 88th Annual Meeting of the American Thyroid Association (Washington, DC, USA October 1–5 2018).
16. Bouillon R. (2019) Skeletal and extra-skeletal actions of vitamin D: current evidence and outstanding questions. Endocr. Rev., vol. 40, no 4, pp. 1109–1151.
17. Schini M. (2020) Normocalcemic Hyperparathyroidism: Study of its Prevalence and Natural History. J Clin Endocrinol Metab, vol. 105, pp. 1–13.
18. Eastell R. (2014) Diagnosis of asymptomatic primary hyperparathyroidism: proceedings of the Fourth International Workshop. J Clin Endocrinol Metab, vol. 99, no 10, pp. 3570–3579.
19. Grant W.B. (2020) Evidence that Vitamin D Supplementation Could Reduce Risk of Influenza and COVID-19 Infections and Deaths. Nutrients,
20. vol. 12. pp. 988–996. doi:10.3390/nu12040988 www.mdpi.com/journal/nutr
21. Khan A.A. (2019) Standards of care for hypoparathyroidism in adults: a Canadian and International Consensus. European Journal of Endocrinology, no 180, pp. 1–23.
